PR Newswire - Kexing Biopharm's Human Umbilical Cord Mesenchymal...
SHENZHEN, China, Sept. 17, 2025 /PRNewswire/ -- Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug...
Read More